Literature DB >> 28033446

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.

Jim C Hu1, Paul Nguyen2, Jialin Mao3, Joshua Halpern1, Jonathan Shoag1, Jason D Wright4, Art Sedrakyan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28033446      PMCID： PMC5470389          DOI： 10.1001/jamaoncol.2016.5465

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

2.  Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening.

Authors:  Ahmedin Jemal; Jiemin Ma; Rebecca Siegel; Stacey Fedewa; Otis Brawley; Elizabeth M Ward
Journal:  JAMA Oncol       Date:  2016-12-01       Impact factor: 31.777

3.  Reevaluating PSA Testing Rates in the PLCO Trial.

Authors:  Jonathan E Shoag; Sameer Mittal; Jim C Hu
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

4.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245
  4 in total
  41 in total

1.  Reconsidering the Trade-offs of Prostate Cancer Screening.

Authors:  Jonathan E Shoag; Yaw A Nyame; Roman Gulati; Ruth Etzioni; Jim C Hu
Journal:  N Engl J Med       Date:  2020-06-18       Impact factor: 91.245

2.  Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.

Authors:  Stacey A Fedewa; Elizabeth M Ward; Otis Brawley; Ahmedin Jemal
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

3.  Error in Methods Section.

Authors: 
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

Review 4.  Prostate Cancer Research at the Crossroads.

Authors:  Michael M Shen; Mark A Rubin
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

5.  Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey.

Authors:  Jarrett A Johnson; Richard P Moser; Gary L Ellison; Damali N Martin
Journal:  J Community Health       Date:  2020-10-16

6.  [Trivialization of prostate cancer? : Stage shift and possible causes].

Authors:  M Saar; M S K M Abdeen; C Niklas; Z T F Al-Kailani; S Siemer; M Stöckle
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

7.  Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.

Authors:  Scott P Kelly; William F Anderson; Philip S Rosenberg; Michael B Cook
Journal:  Eur Urol Focus       Date:  2017-11-20

8.  Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.

Authors:  Ricardo A Rendon; Ross J Mason; Karim Marzouk; Antonio Finelli; Fred Saad; Alan So; Phillipe Violette; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2017-10       Impact factor: 1.862

9.  Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?

Authors:  Izak Faiena; Stuart Holden; Mathew R Cooperberg; Stuart Holden; Howard R Soule; Jonathan W Simons; Todd M Morgan; David F Penson; Alicia K Morgans; Maha Hussain
Journal:  J Clin Oncol       Date:  2018-02-05       Impact factor: 44.544

10.  Making the grade: The newest US Preventive Services Task Force prostate cancer screening recommendation.

Authors:  Richard M Hoffman; Robert J Volk; Andrew M D Wolf
Journal:  Cancer       Date:  2017-08-22       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.